> Study Type : Interventional (Clinical Trial)
> Estimated Enrollment : 51 participants
> Intervention Model: Single Group Assignment
> Masking: None (Open Label)
> Primary Purpose: Treatment
> Official Title: A First-in-Human, Multi-centre, Open-label, Phase 1 Clinical Study With RNA Oligonucleotide Drug MTL-CEBPA to Investigate Its Safety and Tolerability in Patients With Advanced Liver Cancer
> Actual Study Start Date : March 1, 2016
> Estimated Primary Completion Date : September 2018
> Estimated Study Completion Date : December 2018
>>1113
お前、やっぱ baka だったな。
これ以上、ボケ老人とコメントしても意味がないよ。
だから、言ったろ、「フェーズⅠ・フェーズⅡa」を通しで行う試験だって。
アッフォー・アッフォー
> どこにフェーズ1完了とかいているのか？
> Study Type : Interventional (Clinical Trial)
> Estimated Enrollment : 51 participants
> Intervention Model: Single Group Assignment
> Masking: None (Open Label)
> Primary Purpose: Treatment
> Official Title: A First-in-Human, Multi-centre, Open-label, Phase 1 Clinical Study With RNA Oligonucleotide Drug MTL-CEBPA to Investigate Its Safety and Tolerability in Patients With Advanced Liver Cancer
> Actual Study Start Date : March 1, 2016
> Estimated Primary Completion Date : September 2018
> Estimated Study Completion Date : December 2018